Trisalus Life Sciences, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
TriSalus Life Sciences is registering for resale up to 130,805 shares of its common stock issuable upon the exercise of a warrant held by OrbiMed.